89bio, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 28.84 million compared to USD 25.57 million a year ago. Basic loss per share from continuing operations was USD 0.54 compared to USD 1.26 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.95 USD | +0.11% | -1.54% | -19.87% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.87% | 880M | |
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |
- Stock Market
- Equities
- ETNB Stock
- News 89bio, Inc.
- 89bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023